Uncategorized
September 27, 2022
Julie Allickson, Ph.D. on Mayo Clinic Q&A Podcast
Through research, clinical trials and biomanufacturing, Mayo Clinic’s Center for Regenerative Biotherapeutics is working to develop new types of medicines derived from the human body to treat chronic and age-related diseases. Biologics are therapies that come from human sources — cells, blood, enzymes, tissues, genes or genetically engineered cells — for use in medicines. Biomanufacturing is focused on […]
Tags: #3D printing, #Biomanufacturing, #Cancer, #cell therapy, #Dr. Julie Allickson, #gene therapy, #Mayo Clinic Center for Regenerative Biotherapeutics
September 20, 2022
Stem cells show therapeutic hope for chronic lung rejection
Stem cells show potential to safely slow progression of organ rejection in some lung transplant recipients, according to early Mayo Clinic research. This discovery offers hope of one day providing a cellular therapeutic to extend the lives of patients who would not qualify for a second lung transplant after organ rejection. The research team of […]
September 16, 2022
Regeneration after rare cancer
Alison O’Neill’s love for life is as infectious as her grateful attitude. “I’ve been blessed beyond measure. I absolutely love and appreciate life to the fullest. We (my husband and I) love to golf, play tennis, work out, hike and travel,” says Alison. With a bright outlook and a healthy lifestyle, Alison never expected that […]
Tags: #Alison O'Neill, #Angiosarcoma, #broadband light therapy, #Center for Regenerative Biotherapeutics, #Dr. Brittany Howard, #fat grafting, #head and neck cancer, #laser therapy
August 31, 2022
Center for Regenerative Biotherapeutics announces cell and gene therapy accelerator
Mayo Clinic, Hibiscus BioVentures (Hibiscus) and Innoforce announce the launch of Mayflower BioVentures, a cell and gene therapy accelerator dedicated to identifying and forming companies around technologies that address unmet patient needs. This academic and industry relationship will establish independent cell and gene therapy companies to advance the development of Mayo Clinic technologies through preclinical […]
Tags: #Business accelerator, #cell therapies, #gene therapie, #Hibiscus BioVentures, #Innoforce, #Mayo Clinic Center for Regenerative Biotherapeutics
August 30, 2022
A new name for Center for Regenerative Medicine
Mayo Clinic’s Center for Regenerative Medicine has been renamed the Center for Regenerative Biotherapeutics. The name change reflects Mayo’s new strategic focus: manufacturing next-generation biotherapeutics for patients. The new name emphasizes how regenerative medicine at Mayo Clinic has evolved to advance groundbreaking discoveries toward curative products — biotherapeutics — for patients. The Center for Regenerative […]
Tags: #Biomanufacturing, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Medicine
April 15, 2022
Global spotlight on Mayo Clinic’s regenerative biotherapeutics
Mayo Clinic will showcase its work in discovering, manufacturing and delivering next-generation biotherapeutics with an international audience interested in advancing lifesaving cell and gene therapies. Mayo Clinic’s Center for Regenerative Medicine is sponsoring a roundtable discussion, “Mayo Clinic: Building the Ecosystem in Regenerative Biotherapeutics,” at the International Society for Cell & Gene Therapy’s ISCT 2022 […]
Tags: #Dr. Claudia Lucchinetti, #Dr. Julie Allickson, #Dr. Stephen Ekker, #Dr. William Faubion, #International Society for Cell & Gene Therapy, #Manu Nair, #Mayo Clinic Center for Regenerative Medicine
August 12, 2021
Preclinical studies discovered a cell-free bioactive material developed at Mayo Clinic triggered healing of one of the most common shoulder injuries. This Mayo Clinic research, published in Biomaterials, documented that purified exosome product — also known as PEP — promoted repair of rotator cuff injuries faster and more effectively than surgery alone. The rotator cuff […]
Tags: #Bioetherapeutics, #Dr Chunfeng Zhao, #Extracelluar vesicles, #Mayo Clinic Center for Regenerative Medicine, #Purified exosome products, #Regenerative biotherapeutics, #Rotator cuff injuries
July 8, 2021
New strategic focus for Mayo Clinic Center for Regenerative Medicine
Regenerative medicine at Mayo Clinic has successfully focused on driving innovation to help the body’s organs and tissues renew or replace cells. Harnessing the full potential of regenerative therapies makes it possible to repair diseased, injured or congenitally defective tissues and organs. Now, Mayo Clinic’s Center for Regenerative Medicine is expanding to innovate patient care […]
Tags: #biotherapeutics, #Dr. Gregory Gores, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Medicine
June 24, 2021
Demystifying healing potential of stem cells
Mayo Clinic research has discovered proteins secreted by human stem cells that act as a “magic potion” to drive healing after a heart attack. The research uncovered that these cell-released regenerative particles harbor a pattern of functions mirrored in repair of the diseased heart, linking stem cell-transmitted information to the beneficial response of the recipient […]
Tags: #Cardiac regeneration, #cardiopoietic cells, #Dr. Andre Terzic, #Dr. Kent Arrell, #Heart attack, #myocardial infarction
June 4, 2021
New director named for Center for Regenerative Medicine
Julie Allickson, Ph.D., has been named the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine and the Otto Bremer Trust Director, Biomanufacturing and Product Development, Center for Regenerative Medicine. Dr. Allickson joins Mayo Clinic from Wake Forest Institute for Regenerative Medicine at Wake Forest School of Medicine, where she […]
Tags: #Biomanufacturing, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Medicine